Panbela Therapeutics (PBLA) Stock Price, Quote, News & History

Comments

Panbela Therapeutics Inc (PBLA) Stock Price, Quote, News & History

PBLAOTCEM

Trade with Public

$1.11

-0.12-9.76%

At close: Mar 5, 4:00 PM EST

$0.00020

-1.23-99.98%

Pre-Market: Jul 18, 3:00 AM EST

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest

Key Statistics

Open

-

Close

$1.11

Volume / Avg.

0 / 2.86K

Day Range

- - -

52 Wk Range

0.00 - 2.50

Market Cap

$970.00

P/E Ratio

-

Dividend Yield

-

Exchange

OTC

RSI

-

Short Interest

-

Days to Cover

1

Recent Panbela Therapeutics Inc News

What's Going On With Panbela Therapeutics Stock Today?

Panbela Therapeutics announced acceptance of SBP-101 abstract for presentation and disclosed details of a public offering, expecting approximately $9.0 million in gross proceeds.

Nabaparna Bhattacharya

What's Going On With Panbela Therapeutics Stock?

Panbela Therapeutics has a float of only 480,324 shares after the company effected a 1-for-20 reverse split on Jan. 18. Heavy trading volume combined with the small float may be contributing to the stock's large move on Friday.

Erica Kollmann

Panbela Therapeutics (PBLA) Stock Is Down 25%: What's Going On?

Panbela Therapeutics Inc (NASDAQ: PBLA) shares are trading lower by 25% to $1.18 Wednesday afternoon, pulling back following recent, marked strength.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-15.57M

Investing Cash Flow (TTM)

775.00K

Financing Cash Flow (TTM)

14.03M

Free Cash Flow (TTM)

-15.57M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-767.00K

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$6.25M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-17255000.00%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$3.74

Company Debt

Total Debt

$6.39M

LT Debt

$3.19M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$142.00K

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-$1.00M

Key Statistics

Open

-

Close

$1.11

Volume / Avg.

0 / 2.86K

Day Range

- - -

52 Wk Range

0.00 - 2.50

Market Cap

$970.00

P/E Ratio

-

Dividend Yield

-

Exchange

OTC

RSI

-

Short Interest

-

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Panbela Therapeutics Inc is a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company's pipeline assets are ivospemin (SBP-101), FlynpoviTM (eflornithine (...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Panbela Therapeutics (PBLA) stock?

A

You can purchase shares of Panbela Therapeutics (OTCEM:PBLA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Panbela Therapeutics (PBLA) competitors?

A

There are no as such competitors for Panbela Therapeutics.

Q

What is the forecast, or price target, for Panbela Therapeutics (PBLA) stock?

A

Panbela Therapeutics has a consensus price target of $25.00.

Q

What is the current price for Panbela Therapeutics (PBLA)?

A

The stock price for Panbela Therapeutics (OTCEM: PBLA) is $0.0002 last updated March 16, 2026 at 4:56 PM EDT.

Q

Does Panbela Therapeutics (PBLA) pay a dividend?

A

There are no upcoming dividends for Panbela Therapeutics.

Q

When is Panbela Therapeutics (OTCEM:PBLA) reporting earnings?

A

Panbela Therapeutics does not have any upcoming earnings scheduled.

Q

Is Panbela Therapeutics (PBLA) going to split?

A

There is no upcoming split for Panbela Therapeutics.

Q

What sector and industry does Panbela Therapeutics (PBLA) operate in?

A

Panbela Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.

Key Statistics

Open

-

Close

$1.11

Volume / Avg.

0 / 2.86K

Day Range

- - -

52 Wk Range

0.00 - 2.50

Market Cap

$970.00

P/E Ratio

-

Dividend Yield

-

Exchange

OTC

RSI

-

Short Interest

-

Days to Cover

1

Recent Panbela Therapeutics Inc News

What's Going On With Panbela Therapeutics Stock Today?

Panbela Therapeutics announced acceptance of SBP-101 abstract for presentation and disclosed details of a public offering, expecting approximately $9.0 million in gross proceeds.

Nabaparna Bhattacharya

What's Going On With Panbela Therapeutics Stock?

Panbela Therapeutics has a float of only 480,324 shares after the company effected a 1-for-20 reverse split on Jan. 18. Heavy trading volume combined with the small float may be contributing to the stock's large move on Friday.

Erica Kollmann

Panbela Therapeutics (PBLA) Stock Is Down 25%: What's Going On?

Panbela Therapeutics Inc (NASDAQ: PBLA) shares are trading lower by 25% to $1.18 Wednesday afternoon, pulling back following recent, marked strength.

Henry Khederian